ERGOMED

Ergomed is a global contract research organization (CRO) specializing in oncology, rare disease, and complex clinical trials. With more than 25 years of experience and a team of over 100 medical doctors and PhDs, the company supports sponsors from early development planning through trial execution. Its tailored clinical research services are designed to address scientific, operational, and regulatory challenges and help advance the development of safe and effective therapies.

Ergomed’s services span clinical development strategy, trial design, regulatory guidance, clinical trial applications, study start-up, site selection and management, monitoring, project management, and risk-based quality management. The company also offers clinical safety, medical monitoring, data management, biostatistics, programming, medical writing, and quality assurance. Its consulting capabilities include regulatory intelligence, chemistry, manufacturing and controls support, and real-world evidence generation.

Patient-focused support is central to Ergomed’s approach. Through Ergomed CARE™, it supports patients, investigators, and clinical sites, with services intended to improve enrollment, engagement, and retention.